The dynamic process of mammary ductal morphogenesis depends on regulated epithelial proliferation and extracellular matrix (ECM) turnover. Epithelial cell-matrix contact closely dictates epithelial proliferation, differentiation, and survival. Despite the fact that tissue inhibitors of metalloproteinases (Timps) regulate ECM turnover, their function in mammary morphogenesis is unknown. We have delineated the spatiotemporal expression of all Timps (Timp-1 to Timp-4) during discrete phases of murine mammary development. Timp mRNAs were abundant in mammary tissue, each displaying differential expression patterns with predominant localization in luminal epithelial cells. Timp-1 mRNA was unique in that its expression was limited to the stage at which epithelial proliferation was high. To assess whether Timp-1 promotes or inhibits epithelial cell proliferation we manipulated mammary Timp-1 levels, genetically and biochemically. Downregulation of epithelial-derived Timp-1 in transgenic mice, by mouse mammary tumor virus promoter-directed Timp-1 antisense RNA expression, led to augmented ductal expansion and increased number of ducts (P < 0.004). In these transgenics the integrity of basement membrane surrounding epithelial ducts, as visualized by laminin-specific immunostaining, was breached. In contrast to these mice, ductal expansion was markedly attenuated in the proximity of implanted recombinant Timp-1-releasing pellets (rTIMP-1), without an increase in basement membrane deposition around migrating terminal end buds. Epithelial proliferation and apoptosis were measured to determine the basis of altered ductal expansion. Luminal epithelial proliferation was increased by 55% (P < 0.02) in Timp-1-reduced transgenic mammary tissue and, conversely, decreased by 38% (P < 0.02) in terminal end buds by implanted rTIMP-1. Epithelial apoptosis was minimal and remained unaffected by Timp-1 manipulations. We conclude that Timps have an integral function in mammary morphogenesis and that Timp-1 regulates mammary epithelial proliferation in vivo, at least in part by maintaining basement membrane integrity. FIG. 8. Increased mammary ductal growth in Timp-1-reduced transgenic mammary tissue. (A-C) Whole-mounts of the fourth inguinal mammary fat pad from wild-type (wt) and transgenic (5-1) littermates at 45 (A), 50 (B), and 55 days (C). Scale bars, 0.5 cm.
INTRODUCTION
Mammary morphogenesis is a dynamic, yet highly ordered process involving extensive epithelial cell proliferation. This development event initiates with the onset of puberty around 4 weeks of age in mice, as systemic circulation of ovarian hormones begins (Daniel and Silberstein, 1987; Haslam, 1987; Imagawa et al., 1990) . Under the influence of estrogen and progesterone, epithelial penetration into adipose stroma generates a dichotomous tree pattern, which expands by linear lengthening of primary ducts, bifurcation of terminal end buds (TEBs), and secondary lateral branching. TEBs are bulbous structures located at the migrating ductal forefront and contain stem cells that proliferate and differentiate in response to hormones (Dulbecco et al., 1986; Sonnenberg et al., 1986) . Ductal expansion is most rapid between 5 and 8 weeks of age, and by 10 weeks, there is complete infiltration of the fat by a fully developed ductal system. During growth of the ductal tree, extracellular matrix (ECM) molecules are synthesized and deposited as basement membrane or interstitial matrix. The ECM creates physical barriers that must be penetrated to allow for TEB migration and higher orders of lateral branching (Williams and Daniel, 1983) and therefore ECM turnover is inherent to mammary morphogenesis. It is well known that ECM integrity is largely maintained by a balance between the opposing activities of extracellular matrix proteases and their inhibitors (Mignatti and Rifkin, 1993; Woessner, 1991; Gomez et al., 1997) . In vitro, the plasminogen activator/plasmin system affects mammary epithelial branching (Delannoy-Courdent et al., 1998; Fauquette et al., 1997; Delannoy-Courdent et al., 1996) and is known to activate matrix metalloproteinases (MMPs; He et al., 1986) . In turn, MMPs, which can also undergo autoactivation, have been implicated as facilitators of ductal branching in vivo (Sympson et al., 1994; Witty et al., 1995) ; however, the functions of their inhibitors, tissue inhibitors of metalloproteinases (Timps), during this event remain unknown. By virtue of regulating MMP activity, Timps may control the rapid physical expansion of mammary ducts through extracellular matrices by limiting or focusing matrix degradation.
The four murine Timps characterized thus far are designated Timp-1, -2, -3, and -4 (Edwards et al., 1986; Stetler-Stevenson et al., 1989; Leco et al., 1994 Leco et al., , 1997 . Timps are multifunctional proteins capable of influencing the cellular microenvironment both physically and physiologically. Beyond their direct influence on the turnover of structural matrix molecules, Timps can also affect soluble, extracellular factors. This is through the inhibition of at least three other MMP-mediated processes: the processing of cytokines (Gearing et al., 1995) , the degradation of growth factor binding proteins (Thrailkill et al., 1995; Fowlkes et al., 1994a, b) , and the release of ECM-bound growth factors (Whitelock et al., 1996) . Inhibition of the bioavailability of growth-promoting factors suggests that Timps can limit cellular proliferation and this may be the basis of Timps' ability to suppress primary tumor growth (Khokha, 1994; Kruger et al., 1997; Montgomery et al., 1994) . In contrast to these effects, Timps-1 and -2 have been shown to exert mitogenic effects in vitro (Stetler-Stevenson et al., 1992; Bertaux et al., 1991; Hayakawa et al., 1992 Hayakawa et al., , 1994 . Thus, the question remains as to whether mammary Timp expression will negatively or positively affect cellular proliferation in vivo.
To address this question we comprehensively mapped the temporal expression patterns and cell-specific localization of all four Timps during murine mammary morphogenesis. To elucidate further the role of Timps, a gain of Timp-1 function and a loss of Timp-1 function were generated in mammary tissue undergoing ductal development. We achieved this by implanting slow-release pellets containing recombinant human Timp-1 (rTIMP-1; gain of function) and by generating transgenic mice with mammaryepithelial directed Timp-1 antisense RNA expression (loss of function). Enhanced ductal development and basement membrane dissolution was evident following an epithelial-specific loss of Timp-1 function. In contrast, a gain of function impaired local mammary ductal elongation and branching but did not alter basement membranes. Immunohistochemistry linked these developmental changes to altered proliferation, but not apoptosis. This is the first evidence to show that an in vivo manipulation of a single Timp, Timp-1, can regulate epithelial proliferation. We conclude that Timps play an integral role in creating an environment conducive to controlled mammary epithelial ductal progression at least in part by maintaining basement membrane integrity.
MATERIALS AND METHODS

Carmine-Alum Stained Whole Mounts
The fourth inguinal fat pads of virgin mice were removed and placed on a microscope slide for several minutes to adhere to the glass. The tissue was then defatted in Clarke's fluid (75% EtOH, 25% acetic anhydride) for 16 h. After 30 min in 70% EtOH, the tissue was stained in a carmine-alum mix (0.2% carmine, 0.5% aluminum potassium sulfate) for 16 h, followed by 4 -6 h of destaining (2% HCl, 70% EtOH). After dehydration in ascending concentrations of ethanol, the tissue was cleared in toluene and whole-mount images were digitized using Northern Eclipse Software (Empix Imaging, Inc., Toronto, ON, Canada).
RNA Analysis
Total RNA was extracted from a fourth inguinal mammary fat pad as described previously (Chomczynski and Sacchi, 1987) . RNA concentration was determined by measuring the OD 260 on a DU-65 spectrophotometer (Beckman Instruments, Inc., Fullerton, CA). Equal amounts of total RNA were pooled from five mice to determine the average Timp mRNA levels at each time point. RNA was resolved on a 1.1% agarose/5.5% formaldehyde gel, transferred to GeneScreen Plus (NEN Research Products, Inc., Boston, MA), and sequentially hybridized with murine [␣-32 P]dCTP-labeled DNA probes specific for Timp-1, -2, -3, and -4 and 18S rRNA. 32 P-labeled DNA probes were generated by random priming using the Prime-It Kit (Stratagene, La Jolla, CA). Membrane prehybridization, hybridizations, and washes were performed as described (Church and Gilbert, 1984) . For sequential probing, the blot was stripped in 1% SDS, 2 mM EDTA for 5 min at 80°C. Densitometry was performed using Image Quant Software (Sunnyvale, CA) based on 18S RNA as the loading control.
Protein Isolation and Gelatin Zymography
Individual mammary glands were flash-frozen in liquid nitrogen and homogenized in 500 l of extraction buffer (1% Triton X-100, 500 mM Tris-HCl, pH 7.6, 200 mM NaCl, 10 mM CaCl 2 ). The homogenate was centrifuged at 12,000g for 20 min at 4°C and the supernatant stored at Ϫ20°C until needed. Protein concentration was determined using Bradford assay reagents (Bio-Rad Laboratories, Hercules, CA). Twenty micrograms of mammary protein, isolated as described above, was added to 4ϫ sample buffer (10% SDS, 4% sucrose, 0.25 M Tris, pH 6.8) and subjected to SDS-PAGE in a 10% polyacrylamide gel containing 0.1% gelatin. After electrophoresis, the gels were maintained in 2.5% Triton X-100 for 30 min, followed by incubation for 24 h at 37°C in substrate buffer (50 mM Tris, pH 7.5, 5 mM CaCl 2 , 40 mM NaN 3 ). Gels were stained in Coomassie brilliant blue for 30 min at room temperature, followed by destaining (50% methanol, 10% acetic acid). Each lane represents equally pooled mammary protein from five mice, as was done for mammary mRNA levels.
In Situ Hybridization
Strand-specific probes for Timp-1, -2, -3, and -4 were generated as described previously (Harvey et al., 1995) . Nonradioactive riboprobes were generated by incorporating digoxygenin (DIG)-labeled UTP (Boehringer Mannheim, Laval, PQ, Canada) following the manufacturer's instructions. The incorporation of [ 35 S]UTP into radioactive probes was performed as described previously (Inderdeo et al., 1996) . The fourth inguinal mammary fat pads from 35-dayold virgin mice were removed, fixed for 3 h at 4°C in 4% paraformaldehyde, and embedded in paraffin. Both DIG and radioactive in situ hybridization were performed as previously described (Harvey et al., 1995; Inderdeo et al., 1996) .
Elvax-40 Slow-Release Pellets
Elvax-40 pellets (a gift from Dupont, Boston, MA) were washed in several changes of 90% EtOH for 1 week and then dissolved in methylene chloride (10% w/v). Ten micrograms of purified human recombinant Timp-1 protein (Clontech, San Francisco, CA) was added to 125 l of the Elvax solution. This mixture was spread over a 1 ϫ 1-cm area on a glass plate, flash-frozen in liquid nitrogen for 20 min, placed at Ϫ80°C for 2 days, and then air dried at room temperature for another 2 days. This concentration of Timp-1 in Elvax pellets has been previously reported to elicit mouse mammary-specific changes during involution (Talhouk et al., 1992) . Squares (2 ϫ 2 ϫ 0.5 mm) were cut and surgically implanted into the fourth inguinal fat pad (distal to the lymph node) of 30-day-old female mice. Control pellets contained no rTIMP-1. Ten days later the fad pad including the pellet was removed for whole-mount analysis. The release of protein from these pellets was confirmed by overnight incubation of the pellets in PBS followed by PAGE and silver staining, and comparisons were made to nonimpregnated pellets.
Generation and Characterization of Transgenic Lines
An antisense Timp-1 transgene cassette was generated to direct expression specifically to mammary tissue. Full-length Timp-1 cDNA was cloned in the 3Ј to 5Ј orientation downstream of the mouse mammary tumor virus promoter (MMTV-LTR) and an untranslated v-Harvey-ras 500-bp fragment. This MMTV vector was kindly provided by Dr. W. Muller (McMaster University, Canada) . Transgenic mice were generated in an FVB background using standard procedures as described (Hogan et al., 1986) . Two distinct founder animals (5-1 and 7-1) were identified by Southern analysis of tail DNA using a murine Timp-1 [␣-32 P]dCTP-labeled DNA probe. Genotyping of subsequent transgenic progeny was performed by the polymerase chain reaction (PCR), from toe DNA as template and a set of primers from exon 2 (5Ј-GTCATAAGGGCTAAATTCATGGG-3Ј) and exon 3 (5Ј-ACTCTTCACTGCGGTTCTGGGAC-3Ј) of the Timp-1 gene. Transgene-positive animals were identified by amplification of both a 196-bp transgene fragment and a 396-bp endogenous Timp-1 fragment. In wild-type animals, only the 396-bp fragment was evident.
To confirm transgene expression in mammary tissue, total RNA was isolated from various organs from wild-type or transgenic animals and 2.5 g was reverse transcribed at 42°C for 1 h with Superscript reverse transcriptase (RT; Gibco, Gaithersburg, MD) and oligo(dT) primers. Ten percent of this reaction was amplified by PCR using two primer sets in the same reaction. One set was specific for the transgenic cassette and included a forward primer specific for MMTV-LTR (5Ј-GCCATCCCGTCTCCGCTCGTCA-CTTATC-3Ј) and a reverse primer specific for antisense Timp-1 (5Ј-ATCCCTTGGGGCCCGATGACCTGAAG-3Ј). This produces a 550-bp fragment containing the entire 500-bp v-Harvey-ras region in transgene-bearing animals. The other primer set was for murine interleukin-2 (a forward primer, 5Ј-CTAGGCCACAGAATTGA-AAGATCT-3Ј, and a reverse primer, 5Ј-GTAGGTGGAATTCTA-GCATCATCC-3Ј) and yielded a 324-bp fragment. Amplification of interleukin-2 in the same PCR served as a positive control as it confirmed the success of PCR amplification for transgenic and wild-type animals. Southern blotting of the PCR product and subsequent probing with a cDNA specific for the v-Harvey-ras region further confirmed the identity of the transgene-specific PCR product.
RNase Protection Assay
The RNase protection assay was performed using strand-specific probes, essentially as described (Melton et al., 1984) . The Timp-1 antisense probe consisted of a 155-bp internal fragment of the mouse Timp-1 cDNA, and the GAPDH antisense probe was a 70-bp fragment of the mouse GAPDH cDNA (a gift from Dr. D. Edwards, University of East Anglia, UK). Both cDNAs were cloned into the pBluescript plasmid. Riboprobes were generated using T7 RNA polymerase in the presence of [ 32 P]UTP according to established procedure (Melton et al., 1984) .
The decrease in molecular weight of the probe was due to the digestion of single-stranded plasmid polylinker sequences synthesized as part of the riboprobes and demonstrated that the digestion products were specific for the Timp-1 and GAPDH mRNAs. After electrophoresis, the gel was fixed, dried, and exposed on a phosphor screen (Molecular Dynamics, Sunnyvale, CA) for 2 h and densitometric analysis was performed using Image Quant Software (Molecular Dynamics).
Proliferating Cell Nuclear Antigen (PCNA), Laminin, and Collagen Type IV Immunohistochemistry
Mammary tissue was collected, fixed, processed, and sectioned as described for in situ hybridization. Sections were then dewaxed in two changes of xylene, rehydrated through an ethanol series, and placed into 3% hydrogen peroxide for 10 min to block endogenous peroxidase activity. Slides were rinsed in water and microwaved for antigen retrieval in 10 mM citrate buffer, pH 6.0, for PCNA or digested for 40 min at 42°C with pepsin (0.4%, pH 5.2, Sigma, St. Louis, MO) for laminin and collagen type IV antigen retrieval. Slides were rinsed in PBS, incubated with anti-PCNA (1:1000 dilution; Novocastra Laboratories Ltd., New Castle, UK), antilaminin (1:500 dilution; Monosan, Uden, Netherlands), or anticollagen type IV (1:500 dilution; Chemicon, Temecula, CA) antibodies for 1 h in a humid chamber at room temperature, and washed in PBS. Bound antibody was detected using the Level 2 Ultra Streptavidin Detection System (Signet Laboratories, Inc., Dedham, MA) and fresh AEC substrate (3-amino-9-ethylcarbazole; Sigma) as described by the manufacturer. Tissue was counterstained in Mayers hematoxylin, rinsed in PBS, and mounted with crystal mount (Biomeda Corp., Foster City, CA).
Bromodeoxyuridine Immunohistochemistry and Apoptosis Determination
Bromodeoxyuridine (BrdU; Sigma) was dissolved in PBS and administered by ip injection at 75 mg/kg of mouse weight. Two hours later, mice were sacrificed and mammary tissue was collected, fixed, processed, and sectioned as described for in situ hybridization. Sections were then dewaxed in two changes of xylene, rehydrated through an ethanol series, and rinsed in water. After being denatured in 2 N HCl at 37°C for 30 min, sections were neutralized in 0.1 M sodium borate (pH 7.0) for 5 min and then rinsed in water. Sections were then placed into 3% hydrogen peroxide for 10 min to block endogenous peroxidase activity. After a rinse in PBS, sections were blocked with Signet blocking reagent (Signet Laboratories) for 5 min. Antibody specific for BrdU (1:1000 dilution; Sigma) was added to the sections and incubated in a humid chamber for 1 h at room temperature. Detection of bound antibody was identical to the detection of anti-PCNA antibodies. Immunohistological staining of apoptotic cells was performed as described previously (Wijsman et al., 1993) .
Morphometric Analysis
All morphometric analyses were performed on the fourth inguinal mammary fat pad using double-coded slides. For PCNA and apoptosis, counting of positive-and negative-stained epithelial cells was performed in the area distal to the lymph node in transgenic mammary tissue. On the other hand, TEBs and subtending ducts were scored separately for BrdU-positive staining in rTIMP-1-pellet experiments. This approach was taken because the transgenic manipulation occurs throughout the tissue while separate measurements were necessary in the pellet-implanted tissue because of the differential proximity of TEBs and subtending ducts to rTIMP-1-releasing pellets. Histologically, multiple serial sections defined TEBs, which were multicellular club-shaped structures located at the epithelial migrating forefront. The PCNA and BrdU indices were calculated as the number of positive epithelial cells divided by the total number of epithelial cells. An average of 1000 nuclei were scored for PCNA and apoptosis per section, while the average number of TEBs scored for BrdU was 2.5 per section, each containing no fewer than 150 nuclei. The PCNA and apoptotic indices were compared statistically using a one-tailed Student t test, whereas a Student t test for paired samples was performed on BrdU comparisons. Indices were expressed as the means Ϯ SD.
Laminin and collagen type IV morphometry was performed on double-coded slides. To quantitate basement membrane degradation in mammary tissue, immunostaining around epithelial ducts was scored either as continuous or as discontinuous. A minimum of 40 ducts was scored for each tissue section. The percentage of discontinuous ducts in transgenics was compared to that of agematched littermates. Student's t test was used to assess the significance and values were expressed as the means Ϯ SD.
To compare the number of total ducts between transgenic and wild-type mice, we counted the ducts that bisected a randomly generated cross-sectional line in whole mounts at four distinct areas distal to the lymph node. Student's t test was used to assess the significance and indices were expressed as the means Ϯ SEM.
RESULTS
Characterization of Distinct Phases of Mammary Morphogenesis in Virgin Mice
Carmine-alum whole mounts of the fourth inguinal fat pad isolated at discrete ages (15, 25, 35, 55, 75, 95 days) clearly illustrated the progression of mammary ductal development in virgin CD1 female mice. A rudimentary ductal tree consisting of a sparse network of short ducts originated at the teat before puberty (15 days; Fig. 1A ). Ductal elongation initiated at puberty (ϳ25 days; Fig. 1B ) and continued beyond the lymph node (35-55 days; Fig. 1C ) until 75 days when the entire fat pad was completely infiltrated by a fully developed ductal tree. TEBs were located at the forefront of the migrating ducts and were clearly evident at 35 days (Fig. 1C ). Higher orders of branching became more apparent by 55 days (Fig. 1D) , while alveolar-like buds, which form secretory alveoli for milk production during lactation, were seen in mature 75-, 95-, and 140-day-old mice (Figs. 1E and 1F and data not shown). These analyses defined the phases of mammary morphogenesis as a function of age in CD1 mice.
Abundance of Timps and Their Differential Expression in Mouse Mammary Morphogenesis
We determined the temporal changes in Timp mRNA levels ( Fig. 2A ) in mammary tissue representing distinct phases of ductal development and quantified these by densitometry (Figs. 2B-2E). All four Timps were abundant in mammary tissue compared with their differential expression in most murine organs (Leco et al., 1997) . In prepubertal mice, Timp-1 mRNA levels were negligible and Timp-2 levels were very low, which was in contrast to high Timp-3 and -4 expression levels. Of the four Timp mRNAs, a striking 30-fold induction occurred for Timp-1 between 15 and 35 days. This was followed by a sharp decline between 55 and 75 days that remained low in mature mammary tissue. Timp-2 mRNA levels were maximal at day 55, remaining high until 95 days, and declined in 140-day-old tissue. Timp-3 and Timp-4 messages were abundant through all stages, but their levels were also reduced in 140-day-old mammary tissue. Analysis of Timp mRNA levels from individual mice, normalized against 18S rRNA, revealed temporal expression patterns identical to those presented in Fig. 2 (data not shown). As well, the induction of Timp-1 observed at 35 days proved to be highly significant (P Ͻ 0.005). Intriguingly, message levels of Timp-3 and -4 were down-regulated at this age. The narrow window of Timp-1 expression, limited to the stage of active epithelial proliferation, suggested a unique role for this family member during mammary morphogenesis, even though based on exposure times this Timp was lower in abundance compared to others. Further, the reduction of all Timps beyond day 95 correlated with the completion of the majority of ECM turnover in virgin mammary development by this age.
Predominant Epithelial Localization of Timps in Mammary Tissue
To identify the mammary cell types that produce each Timp we performed in situ hybridization in 35-day-old tissue, a stage that expressed all Timps. Overall, each Timp mRNA localized predominantly to luminal epithelial cells. Some expression of Timp-1, -3, and -4 was also observed in fibroblasts surrounding the ducts (Figs. 3A, 3B, 3G, and 3J, arrowhead), while Timp-2 was exclusive to luminal epithelial cells (Figs. 3D and 3E). Timp-3 mRNA was frequently more prominent on one side of the duct (Figs. 3G and 3H) and also localized to histologically defined myoepithelial cells (Fig. 3H, arrowhead) . Timp-4 was unique in that it was present in many mammary cell types, including the condensed cytoplasm of adipocytes and resident mononuculear interstitial cells (Fig. 3K ). The specificity of the hybridization signal was confirmed using the corresponding sensespecific riboprobes, which served as negative controls (Figs. 3C, 3F, and 3L). In addition, no signal was evident in tissue pretreated with RNase A (Fig. 3I ). All Timps were also expressed in TEBs and their cap cells (Figs. 4A-4D, arrowheads) . Timp-1, -2, and -4 (Figs. 4A, 4B, and 4D) were dispersed throughout the entire TEB while Timp-3 (Fig. 4C) appeared localized only to the outermost cellular layer of the TEB, which is composed of cap cells (Daniel et al., 1987) . Due to the low Timp-1 abundance, in situ hybridization was performed with 35 S-labeled Timp-1-specific riboprobes which allowed for increased sensitivity (Figs. 3A-3C and 4A).
Functional Identification of Gelatinase Activity during Mouse Mammary Morphogenesis
Expression of certain MMP mRNAs during mammary morphogenesis has been reported (Witty et al., 1995) , although MMP activity has not been reported. We examined gelatinase activity (Fig. 5 ) since both MMP-2 and MMP-9 are capable of degrading collagen type IV, the main component of basement membrane which surrounds all mammary epithelial ducts. MMP-2 was the predominant active gelatinase present at all time points. As early as 15 days, three gelatinolytic bands, representing pro-MMP-9 (gelatinase-B; 105 kDa), pro-MMP-2 (gelatinase-A; 68 kDa), and activated MMP-2 (60 kDa), were present in mammary tissue. Increased amounts of MMP-2 (both pro and active forms) were detected at 35 days, when pronounced ductal expansion is known to occur. Active MMP-9 (84 kDa) was evident from 25 days onward with maximal activity between 55 and 140 days. These results showed that gelatinases participated in virgin mammary morphogenesis and suggested that extensive basement membrane remodeling was inherent to this event. The fact that gelatinase activity existed at days 95 and 140, after ductal progression has ceased, suggested that this tissue was continually undergoing matrix turnover in the adult mouse.
Impediment of Ductal Progression by Local rTIMP-1 Elevation
Since Timp-1 expression was restricted to a time that precisely corresponded to ductal expansion (Fig. 2B) , our aim was to increase its levels and determine the direct consequence on ductal growth. This was achieved by using ethylene vinyl acetate (Elvax) polymer pellets, which are well characterized for their ability to release incorporated biomolecules over extended time periods (Langer and Folkman, 1976; Rhine et al., 1980) in organs such as the mammary tissue (Jones et al., 1996; Ruan et al., 1995; Vassilacopoulou and Boylan, 1993; Talhouk et al., 1992) . Pellets impregnated with rTIMP-1 were surgically im-planted immediately distal to the migrating TEBs in the fourth inguinal fat pad of 30-day-old mice. This time point was chosen as it represented active ductal expansion. We first confirmed that implanted pellets lacking rTIMP-1 (insert pellet) had no effect on ductal progression (Fig. 6A,  left) . Further, pellets containing rTIMP-1 implanted in one fat pad had no systemic effect on the contralateral fat pad (data not shown). We then simultaneously implanted a pellet containing rTIMP-1 in one fourth inguinal fat pad (Fig. 6B, left) and an inert pellet in the contralateral fat pad (Fig. 6B, right) . The latter were ideal internal negative controls since these two mammary fat pads were exposed to identical systemic hormonal influences. We found that a local rTIMP-1 elevation had clearly impeded ductal elongation when whole-mount analysis was performed 10 days later. A strong attenuation of ductal growth was observed in the immediate vicinity of all implanted rTIMP-1 pellets (Fig. 6B, left) . In comparison, inert pellets lacking rTIMP-1 had no effect in the contralateral tissue since ductal expansion proceeded normally, around and past the pellet (Fig. 6B,  right) . Observations for inert and rTIMP-1 pellets were reproduced in an independent experiment. 
Augmented Ductal Progression in Transgenic Mice with Reduced Mammary Timp-1
We used a genetic approach to determine whether a reduction of mammary Timp-1 levels would also affect epithelial ductal growth. To reduce the epithelial cellderived Timp-1 during mammary development in virgin mice, we expressed Timp-1 antisense RNA from the MMTV-LTR (Fig. 7A) . The MMTV promoter is constitutively active and has mammary epithelial cell specificity, with some promiscuity of expression in other glandular epithelial organs (Muller et al., 1988; Pattengale et al., 1989) . Two independent mouse lines (5-1 and 7-1) were generated from individual transgenic founders. To detect transgene RNA expression, RT-PCR was performed in the same tube using two primer sets: transgene-specific primers and the unrelated murine interleukin-2 gene primers. Antisense-Timp-1 RNA was detected in transgenic mammary ( Fig. 7B) , spleen, and salivary gland tissues (data not shown) of both mouse lines. Samples from control littermates showed only the presence of interleukin-2 mRNA (Fig. 7B ). Strand-specific RNase protection assays confirmed the presence of antisense transcripts in transgenic mammary tissue (data not shown) and allowed us to quantify the levels of Timp-1 mRNA in mammary tissue from transgenic and wild-type littermates (Fig. 7C ). We found a significant 52% reduction of endogenous mammary Timp-1 mRNA levels in transgenics compared to their wild-type littermates (Fig. 7C; 18 .9 Ϯ 3.4 vs 9.0 Ϯ 3.4; P Ͻ 0.012). At the stage of active ductal expansion the 52% reduction of mammary Timp-1 led to augmented ductal growth in 5-1 transgenic animals (Figs. 8A-8C, bottom) compared to their wild-type controls (Figs. 8A-8C, top) . This included a more pronounced linear lengthening and migration of the ductal tree, as well as supernumerary branching. Further, the total number of epithelial ducts was significantly increased by 33% (20.4 Ϯ 1.0 vs 15.1 Ϯ 0.5; P Ͻ 0.004) compared to wild-type littermates. The number of TEBs did not differ significantly between the transgenic and the wild-type littermates. These phenotypes were also seen in the independent transgenic mouse line 7-1 that had reduced mammary Timp-1 expression. In this line, we observed a 38% increase in the number of epithelial ducts at 50 days of age (data not shown).
By 95 days of age, the transgenic and wild-type littermates did not show any overt differences at the wholemount level. This indicated that down-regulation of Timp-1 augmented ductal development at earlier ages, but did not cause sustained mammary hyperplasia. Mammary differences in transgenics and wild types during gestation, lactation, and involution are currently being investigated.
Discontinuous Laminin in Basement Membrane of Timp-1-Reduced Mammary Epithelial Ducts
Basement membrane integrity was assessed in mammary tissue by examining the intensity and continuity of basement membrane proteins around ductal structures (Alexander et al., 1996b; Talhouk et al., 1992; Martinez-Hernandez et al., 1976) . Immunohistochemistry on mammary tissue localized laminin and collagen type IV to the basement membranes surrounding the epithelial ducts (Figs. 9A-9H, data not shown) as well as blood and lymph vessels (data not shown). We found that immunolocalization of laminin was frequently discontinuous, diffuse, or of lighter intensity in Timp-1-reduced tissue (Figs. 9E-9H ). In these transgenics a greater than 2-fold increase (P Ͻ 0.05; n ϭ 4) in the number of ducts that had aberrant laminin signal was observed, compared to their age-matched littermates (Fig. 9I) . In three of four cases, collagen type IV was also frequently discontinuous (1.3-fold greater) and less intense in transgenics than in their wild-type controls (Fig.  9J) . We next set out to determine if Timp-1 reduction resulted in lower total stromal matrix. Utilizing Masson's trichrome staining, which histologically differentiates collagenous material, and Image Quant Software, we quantified mammary stromal matrix content. No significant difference was found in total stromal matrix content between transgenics and wild types ( Fig. 9K; 12 .6 Ϯ 1.9% vs 13.8 Ϯ 0.9%).
To determine if rTIMP-1 released from the implanted pellets affected basement membrane around TEBs we examined laminin and collagen IV immunostaining surrounding these structures. We found that both of these components of the basement membrane became gradually thinner toward the tip of the TEB, while collagen type IV was often absent at the very tip. However, no differences were apparent among TEBs migrating toward pellets releasing rTIMP-1, inert pellets, or no pellets (data not shown). Total stromal matrix content (Masson's trichrome stain) was also not affected by rTIMP-1 slow-release pellets (data not shown).
Timp-1 Affects Mammary Epithelial Proliferation but Not Apoptosis
Mammary epithelium establishes close contacts with the ECM, which then influences its survival by affecting proliferation and apoptosis (Hay, 1993) . To determine the level at which Timp-1 altered ductal expansion, we measured proliferation and apoptosis in Timp-1-manipulated tissue. TEBs migrating toward rTIMP-1-releasing Elvax pellets had significantly fewer proliferating cells (an average reduction of 38%) compared to contralateral tissue in which TEBs were migrating toward an inert pellet or no pellet at all (Figs. 10A-10C; 19.2 Ϯ 2.5% vs 27.6 Ϯ 1.9%; P Ͻ 0.02). No differences were observed in luminal epithelial proliferation in subtending ducts (data not shown). The opposite scenario of increased proliferation was evident in transgenic Timp-1-reduced tissue. We found a significant increase in the number of PCNA-positive epithelial cells in 5-1 mice compared to their age-matched wild-type littermates (Figs. 10D-10F; 38.1 Ϯ 4.6% vs 24.0 Ϯ 1.5%; P Ͻ 0.02). These results demonstrated an average increase of 55% in epithelial proliferation in transgenic Timp-1-reduced mammary tissue.
Apoptosis assessed by in situ end labeling of fragmented genomic DNA was quantified in transgenic and pellet containing and their respective control tissues. Apoptosis was nonexistent in luminal epithelia during virgin mammary morphogenesis and remained unaffected by Timp-1 manipulations (data not shown).
DISCUSSION
Extensive epithelial proliferation, ductal expansion, and branching morphogenesis are processes integral to mouse mammary development. This developmental event has been known for over 70 years and is readily visualized by staining mammary fat pad whole mounts. The four distinct phases, prepuberty, onset of puberty, pronounced ductal expansion, and mature tissue with alveolar-like buds, were clearly evident during mammary development in CD1 mice (Fig. 1) . In this study we have demonstrated that gelatinase activity was evident during mammary morphogenesis (Fig.  5) and that Timps were differentially expressed (Fig. 2) , suggesting that these gene families together provide the controlled proteinase-inhibitor interactions necessary for regulated epithelial ductal growth. The Timps were expressed predominantly in mammary epithelial cells with some expression in stromal cells (Fig. 3) . In addition, all four Timps were found in advancing TEBs (Fig. 4) and their cap cells, which are considered undifferentiated mammary epithelial cells (Daniel et al., 1987) and the target cells for chemical carcinogenesis (Imagawa et al., 1990) . Intriguingly, Timp-1 exhibited a narrow window of expression at the time of most rapid epithelial proliferation when Timps-3 and -4 were down-regulated. We used biochemical (Muller et al., 1988) . The EcoRI fragment represents the full-length encoding region of murine Timp-1 cDNA cloned in the antisense direction. SV40 sequences provide the processing signals. Forward (f) and reverse (r) primers were used in RT-PCR to amplify transgene-specific transcripts. The v-Harvey-ras sequence (p) was used to probe Southern blots for transgene-specific sequences. (B) Reverse-transcribed total RNA from wild-type (wt) and transgenic lines (5-1 and 7-1). Samples from 55-day-old mammary tissue were concurrently amplified with f/r primers for the transgene and with a set of primers specific for interleukin-2 (IL-2; bottom). Amplification of the latter provided internal positive control for PCR amplification. Amplified products were electrophoresed, blotted, and probed with a 32 P-labeled v-Ha-ras sequence (top). (C) RNase protection assay was performed using antisense riboprobes specific for Timp-1 and GAPDH (an internal loading control). The Timp-1 antisense riboprobe is 195 bp (top arrowhead) and its protected fragment is 150 bp (top arrow); the GAPDH riboprobe is 155 bp (bottom arrowhead) and its protected fragment is 75 bp (bottom arrow). A decreased level of Timp-1 transcripts was evident in transgenic (5-1) versus wild-type mammary tissue. and genetic methods to manipulate mammary Timp-1 levels during this window of expression in order to elucidate the functional significance of its tightly regulated mammary expression. We demonstrated that a local rTIMP-1 elevation inhibited ductal elongation (Fig. 6) with no notable effect on basement membrane deposition in the approaching TEBs. In contrast, a reduction of mammary epithelial Timp-1 in transgenic mice augmented linear ductal growth (Fig. 8) while not affecting the number of TEBs. This suggested that a down-regulation of Timp-1 primarily affected lateral side branching and linear lengthening of epithelial ducts, but not TEB bifurcation. Further, we observed discontinuous laminin immunostaining in the basement membranes surrounding ducts (Fig. 9 ). We also showed that these biochemical and genetic manipulations led to altered epithelial proliferation (Fig. 10) , with no effect on apoptosis. It is significant that a 50% reduction in epithelial Timp-1 affected ductal morphogenesis, despite the abundance of other mammary Timps. This provides the first evidence that Timp-1 is able to affect epithelial proliferation in vivo. Further, the diminished epithelial basement membrane integrity during mammary morphogenesis likely contributes in part to increased proliferation, which in turn leads to increased linear lengthening and lateral side branching of ducts.
Since both forward expansion and lateral branching of mouse mammary ducts requires continuous remodeling of matrix molecules (Williams et al., 1983; Silberstein and Daniel, 1982) , matrix-specific proteases would facilitate these dynamic events by removing impeding basement membrane and connective tissue matrix. In support of this, we observed an abundance of active MMP-2 and MMP-9 ( Fig. 5) , indicating that basement membrane degradation is an ongoing process during the period of active ductal expansion and branching. Others have shown that endogenous MMP-3 mRNA localizes to stromal cells along the length of advancing ducts (Witty et al., 1995) and that transgenic mammary expression of autoactivated MMP-3 leads to supernumerary branching from primary ducts (Sympson et al., 1994; Witty et al., 1995) . We propose that the abundance of all four Timps is largely responsible for shielding this environment from excessive MMP-mediated matrix degradation, resulting in controlled remodeling. Our ability to manipulate ductal expansion by altering Timp-1 levels strongly implicated Timp-1 as a regulator of MMPfacilitated mammary ductal expansion.
The degradation of basement membrane may influence the mammary microenvironment in several ways. First, it may remove impeding structural proteins, making way for cellular migration and invasion. Second, it may release growth-promoting or -inhibiting factors sequestered within. Third, it may decrease the cell-ECM contacts needed for cell survival. Finally, it may reveal cryptic sites on degradation products, which in turn can influence cellular function. The main structural components of basement membrane are collagen type IV and the glycoprotein laminin. Several matrix metalloproteinases are capable of degrading laminin and collagen IV. These include the gelatinases (MMP-2 and -9; Okada et al., 1990; Morodomi et al., 1992) , stromelysin-1 (MMP-3; Okada et al., 1987) , matrilysin (MMP-7; Wilson and Matrisian, 1996) , metalloelastase (MMP-12; Chandler et al., 1996) collagenase-3 (MMP-13; Knauper et al., 1997) , and MT-MMPs (MMP-14 to -17; d'Ortho et al., 1997) . The ability of Timps to inhibit these proteinases implicates them as strong candidates in conserving basement membrane integrity and function. We observed discontinuous, diffuse, or lighter laminin immunostaining, but not a decrease in total stromal matrix content in Timp-1-reduced transgenic tissue ( Fig. 9 ). Aberrant laminin staining is likely a result of excessive MMP activity in the vicinity of basement membrane. In vitro, mammary epithelial cells are known to secrete MMPs vectorially toward basement membranes (Talhouk et al., 1991) . We suggest that epithelial-derived Timp-1 reduction leads to a shift in the Timp/MMP balance, increasing MMP activity with local effects on the basement membrane microenvironment, while sparing stromal matrix turnover which may be more closely linked to the proteinase activity secreted by stromal fibroblasts. It is surprising that rTIMP-1 release did not influence matrix deposition around migrating TEBs, given that these structures normally have a minimal basement membrane at their tip (Silberstein et al., 1982) . It is possible that rTIMP-1 elevation during ductal development retarded TEB proliferation independent of matrix perturbation or that MMPs are not the primary proteinases responsible for basement membrane remodeling at the tip of TEBs. For example, the plasmin activator/ plasmin system may be involved in matrix remodeling at the TEB forefront since urokinase plasminogen activator mRNA has been localized to the tips of epithelial cells migrating in three-dimensional collagen gels, with levels correlating to invasiveness (Delannoy-Courdent et al., 1996) .
Our investigations showed that an elevation of mammary Timp-1 inhibited mammary epithelial proliferation in vivo, but did not affect matrix deposition. We have also recently found in a liver tumor model that an elevation of hepatic Timp-1 inhibited transformation-associated hepatocyte hyperplasia in vivo with no overt affects on matrix deposition (Martin et al., 1999) . In light of the emerging concept that MMP activity can release growth factors bound to matrix molecules or cell membranes (Whitelock et al., 1996; Gearing et al., 1995) and process growth factor binding proteins (Thrailkill et al., 1995; Fowlkes et al., 1994a, b) , it is conceivable that MMPs can increase, while Timps can inhibit, the amount of free growth factors within the cellular microenvironment. Reports of cellular hyperplasia following mammary MMP-3 (Witty et al., 1995; Sympson et al., 1994) or epidermal MMP-1 (D'armiento et al., 1995) expression in other transgenic mice support this concept and are consistent with our findings in liver and mammary tissue up-regulated in Timp-1. In our liver tumor model, we have found that increased levels of hepatic Timp-1 suppressed hepatocellular carcinoma by inhibiting the MMPmediated release of insulin-like growth factor-II (IGF-II) from the IGF-II:IGF-binding-protein-3 complex (D. C. Martin and R. Khokha, unpublished results) . IGFs are important mitogens for mammary epithelial proliferation both during mammary development and during tumorigenesis (Ruan et al., 1995) . Changes in the levels of IGF or other growth factors accompanying mammary Timp manipulations during ductal development are currently being investigated.
The ECM is crucial to the maintenance of normal epithelial cell polarity and function in mammary cell cultures (Hay, 1993; Lin and Bissell, 1993) . As well, changes in the ECM affect mammary epithelial gene expression (Lin et al., 1995; Streuli et al., 1995; Lee et al., 1985) , proliferation (Petersen et al., 1992) , and apoptosis (Boudreau et al., 1996; Day et al., 1997) . For example, excessive ECM degradation and/or the loss of cell-ECM contacts induce apoptosis in mammary epithelial cells during mammary involution (Boudreau et al., 1996; Talhouk et al., 1992; Day et al., 1997) , an event shown to be rescued by Timp-1 (Talhouk et al., 1992; Alexander et al., 1996b) . If this was also the case during virgin ductal development, we would anticipate that antisense down-regulation of Timp-1 would induce MMPmediated basement membrane degradation thereby inducing epithelial apoptosis and decreasing ductal expansion. However, our investigations showed that Timp-1 reduction did lead to loss of basement membrane integrity but did not promote mammary epithelial apoptosis. This may be due to three reasons. First, virgin mammary morphogenesis naturally has nonexistent apoptosis. Second, mammary epithelial apoptosis has largely been demonstrated in secretory alveolar epithelia isolated from gestational tissue that is distinct from virgin luminal epithelia. It is possible that the latter is more resistant to changes in cell-ECM contact. This is because secretory alveolar epithelia are surrounded by interspersed myoepithelia and have more contacts with basement membrane while luminal epithelial cells are almost completely encapsulated by myoepithelial cells and thus maintain fewer basement membrane contacts (Warburton et al., 1982) . Finally, our transgenic manipulation has not led to a complete loss of basement membrane, instead it has altered this structure only in localized areas.
In breast cancer, ductal carcinoma in situ is surrounded by an intact basement membrane and progression to malignant invasive ductal carcinoma is facilitated by MMPmediated protease activity (Engel et al., 1994; Davies et al., 1993; Monteagudo et al., 1990; Heppner et al., 1996) . The functional significance of Timp expression in breast cancer, however, is controversial. Due to the presence of high Timp-1 levels in breast cancer specimens (Yoshiji et al., 1996) and the growth-promoting capabilities of Timp-1 in vitro, especially of the human breast cancer cell line MCF-7 (Hayakawa et al., 1992) , it has been suggested that Timp-1 promotes tumorigenicity. Contrary to this, transfection of Timps in tumorigenic cells has led to reduced malignancy, documenting a tumor-suppressive role for Timps (Khokha, 1994) . Here we present the first report that examines directly the effects of Timp-1 on mammary ductal growth in vivo. We clearly demonstrate a significant inhibition of mammary epithelial proliferation upon Timp-1 upregulation with slow-release pellets (Figs. 10A-10C ). Furthermore, we observed the opposite effect of increased epithelial proliferation with a Timp-1 down-regulation in transgenic mammary tissue (Figs. 10D-10F ). Although developmental and cancer events cannot be compared directly, there are parallels, and developmental studies have often been utilized to gain a basic understanding of cancer biology. Given our results, we propose that high Timp-1 levels seen in breast cancer may be a tissue response to increased MMP activity. Identification of factors that influence epithelial proliferation in vivo is of prime importance since breast cancer initiates in epithelial cells.
Human biology is thought to be affected by Timps at many levels, such as bone growth (Cawston, 1998) , embryo implantation (Alexander et al., 1996a) , ovulation (McIntush and Smith, 1998) , emphysema (Ohnishi et al., 1998) , arthritis (Airola et al., 1998) , tumorigenesis (Stetler-Stevenson et al., 1996) , angiogenesis (Sang, 1998) , and metastasis (Liotta et al., 1991) . Timps are grouped as a family because of their conserved regions that allow them to bind with MMPs and inhibit their activity. However, major differences do exist between family members with respect to their MMPbinding constants (Hutton et al., 1998; Taylor et al., 1996) , promoter elements (Borden and Heller, 1997) , localization after secretion (Leco et al., 1994) , and tissue-specific expression (Leco et al., 1997) . Since all Timps are abundant in mammary tissue, unlike most other organs, it becomes increasingly important to understand the functional uniqueness of each Timp in vivo in breast tissue. Here, we have demonstrated that manipulation of a single Timp, Timp-1, functioned to affect the fundamental process of epithelial proliferation. It remains to be seen whether other Timps will affect this developmental event in a similar manner.
